1. Salerno RA, Lesko LJ . Three years of promise, proposals and progress on optimizing the medicines: a Commentary on the 3rd FDA-DIA-PWG-PhRMA-BIO Pharmacogenomics Workshop. Pharmacogenomics J 2006; 1: 1–4.
2. FDA/DIA Workshop: Co development of drug, biologic, and device products, July 2004, Arlington, VA,
http://www.diahome.org/Content/Events/04040.pdf
.
3. Drug-diagnostic co-development – preliminary concept paper, FDA publication, not for implementation:
http://www.fda.gov/cder/genomics/pharmacoconceptfn.pdf
.
4. Huang S-M . Track 2: introduction: concept paper: drug-diagnostic co-development – introduction: April 12, 2005, Bethesda, MD,
http://www.fda.gov/cder/offices/ocpb/workshops.htm
.
5. Hinman L . Track 2 industry comments, April 12, 2005, Bethesda, MD,
http://www.fda.gov/cder/offices/ocpb/workshops.htm
.